Exposure Keratitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-08-06
Clinical Trial Update: The Role of OmniLenz® in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU Patients [Phase 2, Phase 3]
The document notes completion of Phase 2 and Phase 3 trials evaluating OmniLenz® for small corneal perforations due to exposure keratitis in…